Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Zinc levels and lymphocyte counts might be important in heart disease development.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Vitamin A affects hair loss and immune response in alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Oral tofacitinib successfully treated total body hair loss in one patient.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

People with HIV and low T cell counts have more hair and scalp problems.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Tph cells are linked to the severity of systemic lupus erythematosus.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.